Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:28 AM ET Form 4
Insider Buying Village Farms International, Inc. VFF

Village Farms International CEO Michael A. Degiglio Buys $101K of Stock

Michael A. Degiglio, CEO, bought 35,000 shares of Village Farms International, Inc. at $2.89 a share, worth $101K in total on Sep 22, 2026. Shares held after the trade: 9,730,775 (+0.4%).

Value
$101K
Shares
35,000
Price
$2.89
Role
CEO
Holding change
+0.4%
Trade date
Sep 22, 2026
7:12 AM ET 8-K
Leadership Change Group 1 Automotive Inc GPI

Group 1 Automotive Leadership Change

Group 1 Automotive has appointed Benjamin Hart, an analyst at major shareholder Conifer Management, to its Board of Directors, effective November 1, 2026. The appointment is part of a stockholder agreement that includes customary standstill and voting provisions, requiring Conifer to vote in favor of Board recommendations. In connection with the appointment, the Board will expand from ten to eleven members.

Counterparty
Conifer Management, L.L.C.
7:12 AM ET 8-K
Capital Raise Willis Lease Finance Corp WLFC

Willis Lease Finance Capital Raise of $35M

Willis Lease Finance Corporation entered into a purchase agreement to issue 1,750,000 shares of newly issued 8.09% Series B Preferred Stock to the Development Bank of Japan Inc. in a private placement. The transaction is expected to generate gross proceeds of approximately $35 million to support the company's global aviation services platform and business growth.

Value
$35M
Counterparty
Development Bank of Japan Inc.
7:09 AM ET 8-K
M&A Deal Lexeo Therapeutics, Inc. LXEO

Lexeo Therapeutics Signs $8.3M M&A Deal with Mantle Therapeutics Inc.

Lexeo Therapeutics entered into a definitive agreement to acquire Mantle Therapeutics for an upfront purchase price of $5.3 million in cash and $3.0 million in common stock. The deal includes up to $12.0 million in contingent development and regulatory milestone payments plus a $1.0 million cash payment upon specific events, aimed at expanding Lexeo's Friedreich ataxia (FA) pipeline with new CNS-targeted modalities.

Value
$8.3M
Counterparty
Mantle Therapeutics Inc.
7:09 AM ET 8-K
Clinical Trial Data Celldex Therapeutics, Inc. CLDX

Celldex Therapeutics Clinical Trial Data

Celldex reported positive topline results from its Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of barzolvolimab in chronic spontaneous urticaria (CSU), meeting the primary and all key secondary endpoints. The data showed rapid and sustained efficacy through 24 weeks, including in patients refractory to omalizumab, with a favorable safety profile. The company plans to submit a Biologics License Application (BLA) to the FDA in 2027.

Earnings call
Sep 22, 2026, 8:00 AM ET

“The results from our two Phase 3 EMBARQ-CSU trials showed efficacy that is best-in-disease in CSU. We believe barzolvolimab is well-positioned to address large CSU populations of high unmet need—as a first-line therapy for patients with severe CSU or angioedema, and as the second-line advanced therapy of choice.”

Anthony Marucci, Co-Founder, President, and Chief Executive Officer at Celldex

“Barzolvolimab continued to show unprecedented complete response rates across the overall studies and demonstrated strong differentiation in patient populations underserved by existing therapies, including those with severe disease or angioedema, and those whose disease is refractory to omalizumab.”

Diane Young, MD, Senior Vice President and Chief Medical Officer of Celldex
7:09 AM ET 8-K
M&A Deal Ligand Pharmaceuticals Inc LGND

Ligand Pharmaceuticals Signs $23M M&A Deal with Sydnexis, Inc.

Ligand Pharmaceuticals acquired royalty and milestone payment rights for Ryjunea from Sydnexis for $23 million upfront. Ryjunea is a treatment for pediatric myopia licensed to Santen Pharmaceutical in the EMEA region, where it is already approved. Ligand will receive tiered royalties ranging from low-double-digits to high-teens on net sales in those territories.

Value
$23M
Counterparty
Sydnexis, Inc.
7:06 AM ET 8-K
Clinical Trial Data Viking Therapeutics, Inc. VKTX

Viking Therapeutics Clinical Trial Data

Viking Therapeutics announced positive topline results from a maintenance study of its GLP-1/GIP agonist VK2735, demonstrating that less frequent dosing (monthly and every other week) effectively maintained weight loss. Subjects receiving weekly 17.5 mg doses achieved 22% placebo-adjusted weight loss at Week 33, and the drug showed excellent tolerability with GI adverse event rates similar to placebo during the maintenance phase.

Earnings call
Sep 29, 2026, 8:00 AM ET

“The results of our innovative maintenance dosing study continue to demonstrate the significance of VK2735’s unique and differentiated half-life and PK profile, which appear to enable an effective new approach to achieving and maintaining the weight loss goals of patients living with obesity.”

Brian Lian, Ph.D., chief executive officer of Viking

“We believe this dose-ranging study clearly demonstrated the potential viability of novel, extended dosing approaches for maintenance following induction with an incretin-based therapy.”

Brian Lian, Ph.D., chief executive officer of Viking
7:06 AM ET 8-K
Business Update Tonix Pharmaceuticals Holding Corp. TNXP

Tonix Pharmaceuticals Holding Business Update

Tonix Pharmaceuticals announced a new agreement with a major pharmacy benefit manager to provide coverage for TONMYA to approximately 21 million Medicare Part D beneficiaries. This expansion brings the total commercial and government payer coverage for the fibromyalgia treatment to approximately 166 million individuals, or 53% of the total U.S. population.

7:06 AM ET 8-K
Leadership Change Cypherpunk Technologies Inc. CYPH

Cypherpunk Technologies Leadership Change

Cypherpunk Technologies appointed Amanda Fabiano, a veteran digital asset mining executive, to its Board of Directors as a Class III director. Mrs. Fabiano will receive an initial grant of 150,000 RSUs and an annual grant of 100,000 RSUs as part of her compensation package. The appointment coincides with the company's operational launch of its Zcash mining fleet, which recently generated over 3,000 ZEC for its treasury.

Counterparty
Amanda Fabiano
Term
through 2029 Annual Meeting
7:06 AM ET 8-K
Financial Results Millerknoll, Inc. MLKN

Millerknoll Financial Results

MillerKnoll reported Q1 fiscal 2027 net sales of $923.4 million, a 3.4% decrease year-over-year, while diluted EPS rose 31% to $0.38. Results were bolstered by a $10 million net benefit from U.S. government tariff refunds, which contributed $0.11 to diluted EPS and improved operating margins by 110 basis points.

Term
Q1 2027
Earnings call
Sep 22, 2026, 8:30 AM ET

“We delivered strong first quarter earnings, above expectations, reflecting solid execution across the enterprise. Despite softer than expected demand patterns in the quarter, we remain confident in our earnings outlook for the second quarter and full fiscal year. We are directing our efforts toward three key areas: focused priority setting, disciplined cost management, and strengthening our balance sheet for long-term value creation. Our results this quarter reflect the early impact of this work, and we expect this progress to continue”

Jeff Stutz, Interim Chief Executive Officer
7:05 AM ET Form 4
Insider Buying enCore Energy Corp. EU

enCore Energy CEO Richard H. Little Buys $10.6K of Stock

Richard H. Little, CEO, bought 10,000 shares of enCore Energy Corp. at $1.06 a share, worth $10.6K in total on Sep 21, 2026. Shares held after the trade: 60,000 (+20.0%).

Value
$10.6K
Shares
10,000
Price
$1.06
Role
CEO
Holding change
+20.0%
Trade date
Sep 21, 2026
7:02 AM ET 8-K
M&A Deal Cognex Corp CGNX

Cognex Signs $500M M&A Deal with RealSense, Inc.

Cognex Corporation has entered into a definitive agreement to acquire RealSense, Inc., a leader in 3D depth-sensing cameras and robotic perception technology, for $500 million in cash. The deal expands Cognex's presence in the high-growth robotic perception and Physical AI markets and is expected to close in the fourth quarter of 2026. Cognex will also implement retention packages for RealSense employees consisting of approximately $50 million in RSUs and up to $69 million in cash payments over three years.

Value
$500M
Counterparty
RealSense, Inc.
Earnings call
Sep 22, 2026, 8:00 AM ET

“RealSense represents a compelling strategic expansion for Cognex into robotic perception, one of the most attractive adjacent markets in machine vision. RealSense brings a leading 3D perception platform with proprietary technology, a strong developer community and a compelling value proposition for customers. Combined with Cognex’s machine vision expertise and global reach, RealSense positions us to offer a full-stack visual intelligence platform, spanning industrial ID, 2D and 3D machine vision measurement to 3D depth perception and robotic navigation, built to serve the full spectrum of Physical AI.”

Matt Moschner, President and Chief Executive Officer of Cognex

“RealSense was built on a simple idea: robots and autonomous systems can’t act intelligently in the physical world if they can’t first perceive it accurately. We’ve called that mission the Visual Cortex of Physical AI. Joining Cognex puts that mission on an entirely new scale, giving us access to a global industrial customer base and go-to-market reach that would have taken us years to build on our own. This is a combination that makes both businesses stronger.”

Nadav Orbach, Chief Executive Officer of RealSense
7:01 AM ET Form 4
Insider Buying electroCore, Inc. ECOR

electroCore Insider Thomas J. Errico Buys $49.1K of Stock

Thomas J. Errico bought 5,000 shares of electroCore, Inc. at $9.82 a share, worth $49.1K in total on Sep 14, 2026. Shares held after the trade: 363,904 (+1.4%).

Value
$49.1K
Shares
5,000
Price
$9.82
Holding change
+1.4%
Trade date
Sep 14, 2026
7:01 AM ET 8-K
Leadership Change PetVivo Holdings, Inc. PETV

PetVivo Holdings Leadership Change

PetVivo Holdings announced the appointment of Jaime K. Pickett to its Board of Directors, effective September 22, 2026, filling a vacancy created by the resignation of Diane Levitan. Dr. Pickett brings over 20 years of experience in veterinary healthcare and executive leadership, including former roles as CEO and President of Hannah Pet Hospitals.

7:01 AM ET 8-K
Leadership Change PetVivo Holdings, Inc. PETV

PetVivo Holdings Leadership Change

Joseph Jasper resigned from the Board of Directors of PetVivo Holdings, Inc., effective September 22, 2026. To fill the vacancy, the Board appointed Michael K. Handley, a life sciences executive with over 25 years of experience in biotechnology and medical devices, as a non-employee director. Handley's background includes raising over $700 million in capital and supporting more than 80 global product launches.

6:56 AM ET 8-K
Financial Results Autozone Inc AZO

Autozone Financial Results

AutoZone reported Q4 2026 net sales of $6.6 billion, a 5.6% increase year-over-year, with diluted EPS rising to $56.05. For the full fiscal year, the company achieved record sales of $20.3 billion and repurchased $2.0 billion of its common stock. Management noted strengthening sales trends in the latter half of the quarter and plans to accelerate growth across its three operating countries in fiscal 2027.

Term
Q4 2026
Earnings call
Sep 22, 2026, 10:00 AM ET

“I want to thank our entire organization for delivering another quarter of sales and earnings growth. In spite of a difficult selling environment the first eight weeks of our quarter, we remained committed to executing on our strategies to grow both our domestic and international businesses.”

Phil Daniele, President and Chief Executive Officer

“Over the last eight weeks of the quarter our sales results strengthened, and we feel we are well positioned for sales growth in fiscal 2027. We opened 175 new stores this past quarter, which included 16 new Mega Hub stores in the U.S.”

Phil Daniele, President and Chief Executive Officer
6:54 AM ET 8-K
Capital Raise Circle Internet Group, Inc. CRCL

Circle Internet Group Capital Raise of $100M

Circle Internet Group issued 1,237,011 shares of Class A common stock to Binance in a private placement for $100 million. Concurrently, the companies expanded their strategic partnership for a five-year term, where Circle will pay Binance incentive fees to promote USDC through Circle's Modular Smart Contract Wallet infrastructure.

Value
$100M
Counterparty
Binance
Term
5 years
6:52 AM ET 8-K
Executive Compensation Pentair plc PNR

Pentair Executive Compensation

Pentair plc appointed Robert W. Hau as Executive Vice President and Chief Financial Officer, effective November 1, 2026, succeeding interim CFO Robert P. Fishman. Mr. Hau's compensation package includes an annual base salary of $775,000, a 100% target bonus, a $200,000 sign-on bonus, and an initial restricted stock unit award valued at $2.5 million. He previously served as CFO of Fiserv, Inc. and TE Connectivity Ltd.

Counterparty
Robert W. Hau
6:46 AM ET 8-K
Business Update U.S. GoldMining Inc. USGO

U.S. GoldMining Business Update

U.S. GoldMining Inc. has completed its 2026 exploration program at the Whistler Gold-Copper Project in Alaska, drilling a record 7,493 meters across 17 core holes. The program targeted high-priority porphyry centers to identify new gold-copper mineralization and expand existing mineral systems. Initial assay results from the program are expected to be released through the end of 2026.

6:46 AM ET 8-K
Leadership Change CNX Resources Corp CNX

CNX Resources Leadership Change

CNX Resources appointed Ravi Srivastava, the current Senior Vice President of Operations, as Chief Financial Officer, succeeding Everett W. Good who is stepping down to pursue other opportunities. Mr. Good will remain as a non-executive employee until October 2, 2026, and will subsequently serve in a consulting capacity to assist with the transition.

6:37 AM ET 8-K
Financial Results Thor Industries Inc THO

Thor Industries Financial Results

THOR Industries reported fiscal year 2026 net sales of $9.61 billion and diluted EPS of $3.38, with results impacted by a soft North American retail market and inflationary pressures. Despite top-line resilience, gross margins were pressured by material costs and affordability concerns, leading the company to initiate strategic restructuring and reorganization efforts. During the fiscal year, the company reduced debt by $59.7 million and repurchased $115.1 million of its common stock.

Term
FY2026

“Our fiscal 2026 proved to be more challenging than we anticipated at the outset of the year due to the headwinds impacting the RV industry. The retail market never reached the inflection point many in the industry expected, as stubborn interest rates, elevated fuel costs and ever-present inflationary pressures have strained household budgets and kept retail soft throughout the critical selling season.”

Bob Martin, President and Chief Executive Officer
6:36 AM ET 8-K
Loan & Debt Henry Schein Inc HSIC

Henry Schein $1.25B Debt Financing with JPMorgan Chase Bank, N.A.

Henry Schein, Inc. entered into a Fourth Amended and Restated Revolving Credit Agreement, increasing its aggregate revolving credit commitments from $1 billion to $1.25 billion. The amendment extends the facility's termination date to September 19, 2031, and modifies certain financial definitions and covenants. The funds are intended for general corporate purposes, including working capital, capital expenditures, stock repurchases, debt refinancing, and potential acquisitions.

Value
$1.25B
Counterparty
JPMorgan Chase Bank, N.A.
Term
through September 19, 2031
6:31 AM ET 8-K
Loan & Debt Aon plc AON

Aon Debt Financing Update

Aon plc filed an 8-K regarding guarantees for multiple series of senior notes issued by its subsidiaries, including Aon Corporation, Aon Global Holdings plc, and Aon North America, Inc. The filing covers a wide range of debt instruments with maturities ranging from 2027 to 2056. These guarantees represent material financial obligations and modifications to the rights of security holders across the company's capital structure.

6:22 AM ET Form 4
Insider Buying Baozun Inc. BZUN

Baozun CEO Wenbin Qiu Buys $39.8K of Stock

Wenbin Qiu, CEO, bought 13,900 shares of Baozun Inc. at $2.85 to $2.88 a share (average $2.87) in 2 transactions, worth $39.8K in total between Sep 18, 2026 and Sep 21, 2026. Shares held after the trade: 1,666,772 (+0.4%).

Value
$39.8K
Shares
13,900
Average price
$2.87
Role
CEO
Holding change
+0.4%
Trade date
Sep 18, 2026 to Sep 21, 2026
6:12 AM ET Form 4
Insider Selling United Microelectronics Corp UMC

United Microelectronics VP Jen-tsung Lin Sells $1.63M of Stock

Jen-tsung Lin, VP, sold 10,000 shares of United Microelectronics Corp at $163.00 a share, worth $1.63M in total on Sep 22, 2026. Shares held after the trade: 1,172,140 (-0.8%).

Value
$1.63M
Shares
10,000
Price
$163.00
Role
VP
Holding change
-0.8%
Trade date
Sep 22, 2026
6:09 AM ET 8-K
Capital Raise Elmet Group Co. ELMT

Elmet Group Capital Raise

The Elmet Group Co. entered into a warrant purchase agreement with Blue Moon Metals Inc., issuing a warrant to purchase up to 1,166,970 shares of common stock at an exercise price of $21.423 per share. The issuance is in consideration for Blue Moon's strategic investment and obligations under a previously disclosed binding letter agreement. The warrants are exercisable for three years starting six months from the date of issuance.

Counterparty
Blue Moon Metals Inc.
Term
3 years
6:07 AM ET Form 4
Insider Selling Eltek Ltd ELTK

Eltek Insider Gad Dovev Sells $36.3K of Stock

Gad Dovev sold 4,260 shares of Eltek Ltd at $8.52 a share, worth $36.3K in total on Sep 17, 2026. Shares held after the trade: 0 (-100.0%).

Value
$36.3K
Shares
4,260
Price
$8.52
Holding change
-100.0%
Trade date
Sep 17, 2026
6:06 AM ET 8-K/A
Capital Raise Host Digital Inc. HOST

Host Digital Capital Raise

Host Digital Inc. filed an amendment to a previous 8-K to correct the name of an underwriter in its underwriting agreement with Cantor Fitzgerald & Co. The filing relates to an ongoing equity offering, though specific proceeds and share counts were not disclosed in this administrative amendment.

Counterparty
Cantor Fitzgerald & Co.
6:02 AM ET 8-K
Capital Raise abrdn Global Infrastructure Income Fund ASGI

abrdn Global Infrastructure Income Fund Capital Raise

abrdn Global Infrastructure Income Fund has commenced a transferable rights offering, allowing shareholders to subscribe for up to 10,545,755 new common shares. Shareholders of record will receive one right for every share held, with three rights required to purchase one new share. The fund entered into a dealer manager agreement with UBS Securities LLC to facilitate the offering, which is scheduled to expire on October 15, 2026.

Counterparty
UBS Securities LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.